Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000891839-19-000026
Filing Date
2019-01-18
Accepted
2019-01-18 16:57:06
Documents
2
Period of Report
2018-08-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3/A  
1 PRIMARY DOCUMENT edgar.xml 3/A 2828
2 attach_1.txt EX-24 2854
  Complete submission text file 0000891839-19-000026.txt   7113
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Issuer) CIK: 0001205922 (see all company filings)

EIN.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MOMENTA PHARMACEUTICALS, INC. 43 MOULTON STREET CAMBRIDGE MA 02138
Business Address
Crane Alan L (Reporting) CIK: 0001294361 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-38624 | Film No.: 19533681